Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
80.38
+0.91 (1.15%)
Dec 5, 2025, 4:00 PM EST - Market closed
Monopar Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 537 | 134 | 5 | 31 | 40 | 70 | |
| Market Cap Growth | 435.37% | 2552.79% | -83.48% | -24.23% | -42.34% | -59.48% | |
| Enterprise Value | 394 | 128 | -3 | 16 | 18 | 52 | |
| Last Close Price | 80.38 | 22.00 | 1.70 | 11.85 | 16.05 | 30.60 | |
| PB Ratio | 3.78 | 2.44 | 0.91 | 3.04 | 2.13 | 4.47 | |
| P/TBV Ratio | 3.79 | 2.44 | 0.91 | 3.04 | 2.13 | 4.47 | |
| Debt / Equity Ratio | 0.00 | - | - | 0.00 | - | - | |
| Quick Ratio | 55.94 | 11.46 | 4.14 | 4.19 | 12.85 | 14.22 | |
| Current Ratio | 56.10 | 11.48 | 4.17 | 4.21 | 12.98 | 14.28 | |
| Return on Equity (ROE) | -26.54% | -51.42% | -107.19% | -72.45% | -52.57% | -44.52% | |
| Return on Assets (ROA) | -17.99% | -29.87% | -53.66% | -39.03% | -30.51% | -26.92% | |
| Return on Capital (ROIC) | -18.44% | -33.32% | -70.38% | -45.36% | -32.94% | -28.73% | |
| Return on Capital Employed (ROCE) | -15.30% | -29.40% | -158.00% | -104.30% | -48.20% | -41.50% | |
| Earnings Yield | -3.62% | -11.62% | -166.13% | -34.34% | -22.52% | -9.00% | |
| Buyback Yield / Dilution | -97.28% | -37.09% | -8.70% | -1.97% | -13.82% | -17.56% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.